Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2018, Article ID 1847894, 6 pages
https://doi.org/10.1155/2018/1847894
Research Article

Relative Risk Chart Score for the Assessment of the Cardiovascular Risk in Young Patients with Ankylosing Spondylitis

1Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, Santander, Spain
2Division of Rheumatology, Hospital Comarcal, Laredo, Cantabria, Spain
3Division of Cardiology, Hospital Lucus Augusti, Lugo, Spain
4Division of Rheumatology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IDISSC), Hospital Clínico San Carlos, Madrid, Spain

Correspondence should be addressed to Miguel A. González-Gay; moc.liamtoh@yaggaleugim

Received 5 October 2017; Revised 14 January 2018; Accepted 17 January 2018; Published 15 February 2018

Academic Editor: Bruce M. Rothschild

Copyright © 2018 Javier Rueda-Gotor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. van der Linden, H. A. Valkenburg, and A. Cats, “Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria,” Arthritis & Rheumatology, vol. 27, no. 4, pp. 361–368, 1984. View at Publisher · View at Google Scholar · View at Scopus
  2. N. N. Haroon, J. M. Paterson, R. D. Inman, and N. Haroon, “Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study,” Annals of Internal Medicine, vol. 163, pp. 406–416, 2015. View at Publisher · View at Google Scholar
  3. M. F. Piepoli, A. W. Hoes, S. Agewall et al., “European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the european association for cardiovascular prevention & rehabilitation (EACPR),” European Heart Journal, vol. 37, pp. 2351–2381, 2016. View at Google Scholar
  4. J. Rueda-Gotor, A. Corrales, R. Blanco et al., “Atherosclerotic disease in axial spondyloarthritis: increased frequency of carotid plaques,” Clinical and Experimental Rheumatology, vol. 33, pp. 315–320, 2015. View at Google Scholar
  5. J. Rueda-Gotor, J. Llorca, A. Corrales et al., “Carotid ultrasound in the cardiovascular risk stratification of patients with ankylosing spondylitis: results of a population-based study,” Clinical and Experimental Rheumatology, vol. 34, pp. 885–892, 2016. View at Google Scholar
  6. J. Rueda-Gotor, J. Llorca, A. Corrales et al., “Cardiovascular risk stratification in axial spondyloarthritis: carotid ultrasound is more sensitive than coronary artery calcification score to detect high-cardiovascular risk axial spondyloarthritis patients,” Clinical and Experimental Rheumatology, Article ID 28850022, 2017. View at Google Scholar
  7. P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai, “C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,” The New England Journal of Medicine, vol. 342, no. 12, pp. 836–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Gonzalez-Juanatey, T. R. Vazquez-Rodriguez, J. A. Miranda-Filloy et al., “The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease,” Medicine, vol. 88, no. 6, pp. 358–365, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. P. J. Touboul, M. G. Hennerici, S. Meairs et al., Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012; 34 : 290-6.
  10. A. Corrales, C. González-Juanatey, M. E. Peiró, R. Blanco, J. Llorca, and M. A. González-Gay, “Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study,” Annals of the Rheumatic Diseases, vol. 73, no. 4, pp. 722–727, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S. A. Doggrell, C. P. Cannon, D. Morrow et al., “C-reactive protein levels and outcomes after statin therapy,” The New England Journal of Medicine, vol. 352, pp. 20–28, 2005. View at Publisher · View at Google Scholar
  12. A. Oza, N. Lu, S. R. Schoenfeld et al., “Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study,” Annals of the Rheumatic Diseases, vol. 76, no. 10, pp. 1737–1742, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. T. A. Pearson, G. A. Mensah, R. W. Alexander et al., “Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association,” Circulation, vol. 107, no. 3, pp. 499–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Mihaylova, J. Emberson, L. Blackwell et al., “The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials,” The Lancet, vol. 380, no. 9841, pp. 581–590, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. P. M. Ridker, E. Danielson, F. A. Fonseca et al., “Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein,” The New England Journal of Medicine, vol. 359, pp. 2195–2207, 2008. View at Google Scholar